COMP <GO>
SYK vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Stryker Corporation (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: SYK 5
— JNJ 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: JNJ
LAST: $291.86 (-6.38%) • MKT CAP: $119.58B
options-implied-move
7.30%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
options-implied-move
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SYK VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SYK | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.00% | 67.90% | -3.90 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.60% | 25.50% | -13.90 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.6x | 18.5x | +5.10 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 3.58% | 2.97% | +0.61 | SYK | /fcf-yield <GO> |
| Operating Margin | 19.50% | 34.70% | -15.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 12.90% | 28.50% | -15.60 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 6.00% | +5.20 | SYK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.07% | 0.00% | +1.07 | SYK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.46 | 5.59 | -1.13 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | SYK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.30% | 7.20% | +0.10 | JNJ | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.0 | 60.4 | -12.37 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 1.08 | +0.05 | SYK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.2x | 23.0x | +11.20 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $119.58B | $662.49B | -$542.91B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SYK REV | JNJ REV | SYK GROSS % | JNJ GROSS % | SYK FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $25.12B | $94.19B | 64.0% | 67.9% | $4.28B | $19.70B |
| FY 2024 | $22.59B | $88.82B | 63.9% | 69.1% | $3.49B | $19.84B |
| FY 2023 | $20.50B | $85.16B | 44.0% | 44.0% | $2.79B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SYK // BETA 1.13
JNJ // BETA 1.08